Zimvie In Share Price: ZIMV (Zimvie In) Stock Price Today & Updates | INDmoney

Question 1

What is Zimvie In share price today?

Accepted Answer

Zimvie In (ZIMV) share price today is {{live_price}}.

Question 2

Can Indians buy Zimvie In shares?

Accepted Answer

Yes, Indians can invest in the Zimvie In (ZIMV) from India.

With INDmoney, you can buy Zimvie In at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Zimvie In at zero transaction cost.

Question 3

How can I buy Zimvie In shares from India?

Accepted Answer

It is very easy to buy Zimvie In from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Zimvie In be purchased?

Accepted Answer

Yes, you can buy fractional shares of Zimvie In with INDmoney app.

Question 5

What are the documents required to start investing in Zimvie In stocks?

Accepted Answer

To start investing in Zimvie In, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Zimvie In

Accepted Answer

Today’s highest price of Zimvie In (ZIMV) is {{1_rba_end}}.

Today’s lowest price of Zimvie In (ZIMV) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Zimvie In

Accepted Answer

Today's market capitalisation of Zimvie In ZIMV is 454.4M

Question 8

What is the 52 Week High and Low Range of Zimvie In

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Zimvie In is down from its 52 Week High?

Accepted Answer

Zimvie In (ZIMV) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Zimvie In is up from its 52 Week low?

Accepted Answer

Zimvie In (ZIMV) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Zimvie In?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Zimvie In

Accepted Answer

Mr. Vafa  Jamali is the current Chief Executive Officer (CEO) of Zimvie In.

Period	Zimvie In	Sector (Health Care)	Index (Russel 2000)
3 Months	-5.95%	-0.2%	0.0%
6 Months	57.83%	9.7%	0.0%
1 Year	60.5%	10.6%	0.0%
3 Years	-36.82%	18.5%	-22.6%

Market Capitalization	454.4M
Book Value	$14.24
Earnings Per Share (EPS)	-1.92
Wall Street Target Price	18.0

Profit Margin	-81.52%
Operating Margin TTM	0.75%

Return On Assets TTM	-0.3%
Return On Equity TTM	-9.04%

Revenue TTM	455.2M
Revenue Per Share TTM	17.07
Quarterly Revenue Growth YOY	-1.7999999999999998%
Gross Profit TTM	613.1M
EBITDA	3.6M
Diluted Eps TTM	-1.92
Quarterly Earnings Growth YOY	0.0

Zimvie In (ZIMV)

Increasing Revenue

Increasing Net Profit

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	0.59
EPS Estimate Next Year	0.74
EPS Estimate Current Quarter	-0.04
EPS Estimate Next Quarter	-0.02

	FY19	Y/Y Change
Revenue	1.1B	↓ 3.97%
Net Income	-27.9M	↓ 93.94%
Net Profit Margin	-2.64%	↑ 39.25%

	FY20	Y/Y Change
Revenue	912.4M	↓ 13.56%
Net Income	-179.0M	↑ 541.58%
Net Profit Margin	-19.62%	↓ 16.98%

	FY21	Y/Y Change
Revenue	1.0B	↑ 11.2%
Net Income	-95.3M	↓ 46.76%
Net Profit Margin	-9.39%	↑ 10.23%

	FY22	Y/Y Change
Revenue	913.9M	↓ 9.93%
Net Income	-63.9M	↓ 32.97%
Net Profit Margin	-6.99%	↑ 2.4%

	FY23	Y/Y Change
Revenue	457.4M	↓ 49.95%
Net Income	-393.3M	↑ 515.65%
Net Profit Margin	-85.98%	↓ 78.99%

	Q4 FY22	Q/Q Change
Revenue	229.1M	↑ 6.78%
Net Income	-30.3M	↓ 3751.5%
Net Profit Margin	-13.24%	↓ 13.63%

	Q1 FY23	Q/Q Change
Revenue	225.4M	↓ 1.61%
Net Income	-30.0M	↓ 1.24%
Net Profit Margin	-13.29%	↓ 0.05%

	Q2 FY23	Q/Q Change
Revenue	224.9M	↓ 0.24%
Net Income	-23.4M	↓ 22.01%
Net Profit Margin	-10.39%	↑ 2.9%

	Q3 FY23	Q/Q Change
Revenue	202.9M	↓ 9.79%
Net Income	-5.1M	↓ 78.23%
Net Profit Margin	-2.51%	↑ 7.88%

	FY19	Y/Y Change
Total Assets	2.1B	-
Total Liabilities	442.3M	-

	FY20	Y/Y Change
Total Assets	1.9B	↓ 7.64%
Total Liabilities	458.7M	↑ 3.71%

	FY21	Y/Y Change
Total Assets	1.8B	↓ 6.28%
Total Liabilities	375.3M	↓ 18.18%

	FY22	Y/Y Change
Total Assets	1.6B	↓ 10.11%
Total Liabilities	883.5M	↑ 135.4%

	Q4 FY23	Q/Q Change
Revenue	113.1M	↓ 44.27%
Net Income	-334.9M	↑ 6479.92%
Net Profit Margin	-296.16%	↓ 293.65%

	Q1 FY24	Q/Q Change
Revenue	118.2M	↑ 4.54%
Net Income	-7.8M	↓ 97.68%
Net Profit Margin	-6.57%	↑ 289.59%

	FY18	Y/Y Change
Operating Cash Flow	162.0M	-
Investing Cash Flow	-50.3M	-
Financing Cash Flow	-97.3M	-

	FY19	Y/Y Change
Operating Cash Flow	119.2M	↓ 26.42%
Investing Cash Flow	-84.6M	↑ 68.19%
Financing Cash Flow	-43.7M	↓ 55.09%

	FY20	Y/Y Change
Operating Cash Flow	86.0M	↓ 27.85%
Investing Cash Flow	-49.5M	↓ 41.49%
Financing Cash Flow	-46.5M	↑ 6.41%

	FY21	Y/Y Change
Operating Cash Flow	64.3M	↓ 25.23%
Investing Cash Flow	-60.3M	↑ 21.82%
Financing Cash Flow	72.3M	↓ 255.48%

	FY22	Y/Y Change
Operating Cash Flow	24.6M	↓ 61.7%
Investing Cash Flow	-28.7M	↓ 52.47%
Financing Cash Flow	-1.3M	↓ 101.81%

	Q4 FY22	Q/Q Change
Operating Cash Flow	-8.9M	↓ 412.17%
Investing Cash Flow	-5.6M	↓ 37.55%
Financing Cash Flow	-16.5M	↑ 369.18%

	Q1 FY23	Q/Q Change
Operating Cash Flow	-7.2M	↓ 19.15%
Investing Cash Flow	-5.8M	↑ 4.91%
Financing Cash Flow	-10.9M	↓ 33.78%

	Q2 FY23	Q/Q Change
Operating Cash Flow	256.0K	↓ 103.56%
Investing Cash Flow	-1.3M	↓ 78.28%
Financing Cash Flow	1.2M	↓ 110.65%

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zimvie In	1.96%	57.83%	60.5%	-36.82%	-36.82%
Stryker Corporation	4.27%	16.65%	22.1%	34.77%	82.03%
Boston Scientific Corp.	4.07%	37.57%	46.89%	79.16%	88.7%
Edwards Lifesciences Corp.	3.26%	26.96%	1.71%	-9.27%	51.45%
Abbott Laboratories	-2.62%	-2.21%	-0.86%	-5.87%	32.8%
Medtronic Plc	0.44%	2.96%	-1.92%	-33.69%	-13.02%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zimvie In	NA	NA	NA	0.59	-0.09	0.0	NA	14.24
Stryker Corporation	38.89	38.89	2.92	11.96	0.19	0.07	0.01	50.33
Boston Scientific Corp.	63.5	63.5	1.8	2.33	0.09	0.05	NA	13.56
Edwards Lifesciences Corp.	37.45	37.45	5.19	2.76	0.21	0.12	NA	11.82
Abbott Laboratories	31.83	31.83	5.99	4.63	0.15	0.06	0.02	22.31
Medtronic Plc	29.48	29.48	1.52	5.2	0.07	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zimvie In	Sell	$454.4M	-36.82%	NA	-81.52%
Stryker Corporation	Buy	$129.9B	82.03%	38.89	16.03%
Boston Scientific Corp.	Buy	$111.1B	88.7%	63.5	12.05%
Edwards Lifesciences Corp.	Buy	$52.4B	51.45%	37.45	23.01%
Abbott Laboratories	Buy	$177.8B	32.8%	31.83	13.96%
Medtronic Plc	Buy	$106.7B	-13.02%	29.48	11.36%

Organization	Zimvie In
Employees	2600
CEO	Mr. Vafa Jamali
Industry	Healthcare